Name: Relmada Therapeutics, Inc. (RLMD) Balance Sheet
Creator: FinSpry

Relmada Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Relmada Therapeutics, Inc. (RLMD) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	3.86	4.09	148.32	44.44	2.50
Short-Term Investments	41.05	92.23	142.93	167.47	114.60
Cash & Short-Term Investments	44.91	96.32	148.32	211.91	117.09
Accounts Receivable	0.00	0.00	0.51	0.09	0.08
Inventory	0.00	0.00	0.00	0.00	0.00
Other Current Assets	0.89	1.19	0.00	0.00	0.90
Total Current Assets	45.80	97.51	152.87	223.30	118.07
Non-Current Assets
Property, Plant & Equipment (Net)	0.00	0.00	0.00	0.00	0.00
Other Non-Current Assets	0.02	0.04	0.03	0.03	0.11
Total Non-Current Assets	0.02	0.04	0.03	0.03	0.19
Total Assets	45.82	97.55	152.91	223.33	118.19
Current Liabilities
Accounts Payable	4.13	3.51	12.47	11.19	8.35
Accrued Liabilities	6.16	8.69	6.19	2.23	4.26
Other Current Liabilities	6.16	0.00	0.00	0.00	1.80
Total Current Liabilities	10.29	12.19	12.47	15.06	12.60
Non-Current Liabilities
Long-Term Debt	0.00	0.00	0.00	0.00	0.00
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	0.00	0.00	0.00	0.00	0.00
Total Liabilities	10.30	12.19	12.47	15.06	12.60
Stockholders' Equity
Common Stock	0.03	0.03	0.03	0.03	0.02
Retained Earnings	-640.88	-560.90	-462.11	-305.07	-179.32
Additional Paid-in Capital	676.37	646.23	602.52	513.30	284.88
Shares Outstanding	30.17	30.10	30.10	27.74	0.00
Total Stockholders' Equity	35.52	85.36	140.44	208.26	105.58
Total Liabilities & Equity	45.82	97.55	152.91	223.33	118.19